Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alembic Pharmaceuticals has informed that the management of the Company shall meet analyst(s)/ investor(s) on 6th September, 2021 as per the details mentioned in the attached letter.
The above information is a part of company’s filings submitted to BSE.